Abstract
The emphasis in human medicine is gradually shifting from cure to prevention, as exemplified by the advantages being made in immunoprophylaxis. After the establishment of a basic vaccination programme for the entire population, the focus is now on combatting infectious diseases which occur in specific groups of the population as well as on developing vaccines against tropical protozoal diseases. Recent successes in this field include the vaccines against hepatitis B, malaria and meningococcal infections. In addition, efforts are being made to intensify vaccination campaigns in the developing countries through the “Expanded Programme on Immunization” of the WHO. Similar developments are under way in veterinary medicine, where vaccines against parasitic diseases are now generating considerable, interest.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lerner, R.A.: Synthetic vaccines. Sci. American (1983), 248, 48–56
Steward, M.W. and Howard, C.R.: The potential of synthetic peptides for vaccines. Medical Laboratory Sciences, (1985), 42, 376–387
Liew, F.Y.: New aspects of vaccine development. Clin. Exp. Immunol. (1985), 62, 225–241
Davies, J.E.: Genetic engineering and vaccines. Ann. Inst. Pasteur/Immunol. (1985), 136D, 143–150
Korevaar, R.: Biotechnologische vaccins tegen grillige ziekteverwekkers. (Biotechnological vaccines against erratic pathogens.) Toegepaste Wetenschap T.N.O. (1985), 6, 24–29
Storm, P.K.: Veterinaire vaccins op basis van recombinant DNA. (Veterinary vaccines based on recombinant DNA.) Tijdschr. Diergeneeskd. (1983), 108, 3, 109–111
Smith, G.L. et al.: Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature (1983), 302, 490–495
Anonymous: The production of hepatitis B vaccines in yeast. WHO-Chronicle, (1984), 38, 6, 260–261
Ruitenberg, E.J. and Wezel, A.L. van: Biotechnologie en vaccinbereiding. (Biotechnology and vaccine production.) Tijdschr. Diergeneeskd. (1984), 109, 20, 819–821
Bona, C. and Moran, T.: Idiotype vaccines. Ann. Inst. Pasteur/Immunol. (1985), 136C, 3, 299–312
Kreeftenberg, J.G. et al.: Investigations on the immunogenicity of tetanus vaccine in vitro. Sixth International Conference on Tetanus, Dec. 3–5, 1981, Lyon, Fondation Marcel Merieux
UytdeHaag, F.G.C.M. et al.: Induction of antigen-specific antibody response in human peripheral blood lymphocytes in vitro by a dog kidney cell vaccine against rabies virus (DKCV). The Journal of Immunology, (1983), 131, 3, 1234–1239
Loggen, H.G.: Personal communication
UytdeHaag, F.G.C.M. et al.: Human peripheral blood lymphocytes from recently vaccinated individuals produce both type-specific and intertype cross reacting neutralizing antibody on in vitro stimulation with one type of poliovirus. The Journal of Immunology (1985), 135, 5, 3094–3101
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Hendriksen, C.F.M. (1988). Future Prospects. In: Laboratory Animals in Vaccine Production and Control. Developements in Hematology and Immunology, vol 20. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1321-9_13
Download citation
DOI: https://doi.org/10.1007/978-94-009-1321-9_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7088-1
Online ISBN: 978-94-009-1321-9
eBook Packages: Springer Book Archive